The eosinophil granule major basic protein (MBP) 1 is an arginine rich, highly basic, 9,300 dalton protein, which forms the crystalloid core of the granule (1-3) and is present in small amounts in basophils (4). MBP is toxic to parasites (5-7) and is deposited onto the surface of damaged microfiliariae in Onchocerca volvulus infestation (8). MBP is also toxic to cells (5, 9) and causes desquamation of respiratory epithelial cells in vitro (10, 11). Finally, MBP triggers histamine release from human basophils and rat mast cells (12).
* This category includes placental tissues from single or few cases of severe preeclampsia, twins, pruritic urticarial plaques and papules of pregnancy (PUPPP) syndrome, fetal anencephaly, placenta accreta, placental abruption, and retained placenta; other tissues included endometriosis (hysterectomy specimen) and maternal skin.
Immunofluorescence Localization of MBP. The indirect immunofluorescence method has been described in detail (14) (15) (16) . Briefly, formalin-fixed, paraffin-embedded tissue was sectioned at 6 #m and glued to glass microscope slides. Sections were deparaffinized, rehydrated, and digested with trypsin. Tissues were washed and incubated under 10% normal goat serum to inhibit nonspecific interactions between second stage reagents and the tissue. They were incubated with either affinity-purified rabbit anti-MBP antibody or protein A affinity-purified normal rabbit IgG as a control, followed by washing, treatment with chromotrope 2R to prevent nonspecific eosinophil fluorescence, repeat washing, and exposure to the second stage goat anti-rabbit Ig antibody conjugated with fluorescein isothiocyanate. After a final wash, sections were sealed under coverslips, using a glycerol/ phosphate-buffered saline (PBS) (9:1) mounting medium made 10 mg/ml in para-phenylenediamine to inhibit fluorescence fading. Immunofluorescence microscopy used a Zeiss microscope fitted with Zeiss IV FL vertical illumination for epifluorescence and a fluorescein filter system (Carl Zeiss, Inc., Thornwood, NY). In some instances, sections showing positive immunofluorescence were photographed, the coverslip was soaked off, the section was counterstained with hematoxylin and eosin (HE), and areas of interest were photographed again to permit direct correlation between fluorescent structures and conventional histoiogic landmarks. Photomicrography was carried out using Kodak Ektachrome 400 ASA slide film (fluorescence) or Kodak Ektachrome 64 ASA slide film (HE counterstains) in a Zeiss M35 camera back mounted with power winder. The exposure time for fluorescence was 60 s.
Giemsa Staining for Eosinophils. Tissue specimens were processed as described by Godfrey et al. (17) to determine whether eosinophils were present in placenta. Briefly, fresh tissue was reduced by sharp dissection to 2-mm cubes, immersed in Karnovsky's fixative (18) for 2 h at room temperature, and incubated in the cold overnight in 0.2 M cacodylate buffer. Fixed tissue was embedded in methacrylate and 2-tzm sections were cut and mounted on glass slides. Sections stained with Giemsa at pH 6.5 were examined by light microscopy. 14,797 M Na~HBO4/NaH2BO4 * Recoveries are expressed as nanograms MBP per gram (wet weight) tissue, determined in the twosite immunoradiometric assay. * Placental extracts were reduced in 0.0075 M dithiothreitol and they were incubated at room temperature for 60 rain. Extracts were alkylated with iodoacetamide, final concentration 0.015 M, and they were incubated for 20 rain at room temperature. See reference 13 for a complete discussion of the previously established need for reduction and alkylation in immunochemical detection of MBP.
Extraction of MBPfrom
glass Dounce instrument, using 100 strokes. In some instances, minced tissue fragments were digested with 0.1% collagenase in Dulbecco's PBS at 37°C for 18 h before homogenization. Homogenates were centrifuged at 40,000 g for 1 h and the supernatants were analyzed for MBP by radioimmunoassay. In two instances, immediately after delivery, placental septal or chorionic plate cysts were identified and subjected to needle aspiration. Cyst contents were serous, strawcolored fluids.
Radioimmunoassay of Tissue Extracts and Cyst Fluids.
The assays used for the determination of MBP have been described in detail elsewhere (13, 19) . A double antibody inhibition assay (19) was used both for extracts and cyst fluids, and a two-site immunoradiometric assay (13) was used for extracts and for monitoring of column fractions resulting from gel permeation chromatography of extracts.
Chromatography of Placental Extracts. A 1.6 × 50-cm Sephadex G-50 column was equilibrated with 0.15 M NaCl, 0.01 M HCI at 4 o C. Tissue extracts prepared as described in Table II were centrifuged at 40,000 g for 60 min, made 5-10% in sucrose, and applied to the column under the eluent. In experiments using placental extracts not reduced and aikylated during tissue extraction, the sample was reduced and alkylated as described previously for pregnancy serum (13) before application to the column. Elution was carried out at a flow rate of 5 ml/cm 2 per hour and 2.7-ml fractions were collected.
Results
Localization of Immunoreactive MBP by Immunofluorescence. Fig. 1 shows the typical pattern of MBP immunofluorescence localization in term placentae. Immunofluorescence staining was limited to anchoring villi and was present at both cellular and extracellular sites; no tissue elements of absorptive villi, including syncytiotrophoblast, cytotrophoblast, Hofbauer cells, and fetal vasculature were stained. The cellular staining was confined to X cells, the large round cells found in anchoring villus and placental floor but not in absorptive villi. Higher magnifications show that only certain X cells have intense, diffuse cytoplasmic staining. Some X cells are less intensely stained, showing predominantly perinuclear speckling, and some do not stain at all. The extracellular substance showing such intense fluorescence is, when viewed by transmitted light in HEstained sections, a palely eosinophilic, ground glass-appearing material, clearly Fmtsgz 1, lmmunofluorescence for MBP in delivered normal placenta. In this figure all panels are views of one tissue section, processed first for MBP immunofluorescenee, photographed, and then counterstained with HE and again photographed. An exception to this is C, which is ~a section serial to that shown in the other panels, processed for immunoBuorescence using normal rabbit lgG (instead of rabbit anti-MBP antibody) as a negative control. A is a low power view of placenta. The small islands of tissue are the absorptive villi (arrowheads), surrounded by the maternal blood space (b); in this section most of the blood has been washed out. The large central connective tissue structure (v) is an anchoring villus. B shows a higher magnification of the anchoring villus indicated by the box in A. The large round cells are X cells, the predominant cell type of the anchoring villus, and they are surrounded by a pale, ground glass-appearing substance. C is the serial section immunofluorescence-negative control Although affinity-purified antibody was used exclusively for the figures shown here, o u r initial experiments, which gave identical results, were made using whole rabbit antiserum to MBP. Tests o f the specificity of this antiserum were carried out and the results are shown in T a b l e III. I m m u n o f l u o r e s c e n t staining of placenta was not altered by absorption with an unrelated basic protein, protamine, but was completely abolished by absorption with MBP-Sepharose. Further, neither preimmunization sera obtained from the same rabbit n o r serum of a n o t h e r animal immunized with complete Freund's adjuvant alone stained placenta.
In addition to these immunochemical tests of specificity, we d e t e r m i n e d whether immunofluorescent staining of placenta simply reflected the presence of maternal serum containing high levels of immunoreactive MBP. Maternal skin was resected at the time of cesarean section and was tested for immunofluorescence; no staining was found. Similarly, when maternal blood was clotted, formalin fixed, paraffin e m b e d d e d , and stained for MBP, no staining was found except for the occasional brightly fluorescent peripheral blood eosinophil. * The preparation of these adsorbents is described in reference 15. * Protamine was selected as a cationic protein with physicochemical qualities similar to those of MBP; macromolecular interactions based on charge rather than immunologic specificity would likely affect MBP and protamine to a similar extent. J This was preimmunization serum obtained from the same animal from which the postimmunization specific antiserum tested in a was obtained.
presence or absence of uterine labor had no effect on fluorescence, inasmuch as placentae obtained by elective cesarean section were indistinguishable from placentae delivered spontaneously. Because initial immunofluorescence observations were made on third trimester-delivered placentae, we investigated placental MBP immunofluorescence during earlier stages of gestation. All 14 placentae examined from first and second trimester terminations of pregnancy (7 from each trimester) and a 6-wk spontaneous abortion showed both cytoplasmic and extracellular MBP immunofluorescence comparable to that shown in Figs. 1 and 2 ; the earliest placentae studied were obtained at 6 wk gestation.
The above results indicate that placental anchoring villi and certain of the X cells therein stain for MBP by immunofluorescence. Fig. 3 shows sections obtained from a postpartum hysterectomy where placental bed and decidual structures were found isolated by myometrium but in close proximity. The areas of deep adenomyosis contained only maternal decidual cells and did not stain, while the areas at the placental insertion site, containing X cells and placentalsite giant cells, stained brightly. This observation was confirmed in another specimen by comparison of biopsies of decidua vera (endometrium from the uterine wall opposite the placental insertion site) and decidua basalis (endometrium at the placental insertion site). The decidua vera did not stain while the decidua basalis was strongly positive. These results suggest that MBP immunofluorescence is limited to trophoblastic and not maternal cellular elements at the choriodecidual junction.
Additional evidence favoring a trophoblastic origin for the immunofluorescence-containing cells was obtained from examinations of tissues from ectopic tubal gestations. Cellular immunofluorescence was observed in the conceptus of 10 of 13 tubal gestations, with some extracellular fluorescence in 2 of the 10 positive specimens. Hysterectomy was performed at the time of resection of two of the tubal gestations and the uterine decidual endometrial tissue had no MBP immunofluorescence, while the tubal conceptus, with no surrounding uterine Placentae from single cases of retained placenta, placental abruption, placenta accreta, and two cases of the pruritic urticarial plaques and papules of pregnancy syndrome all demonstrated specific immunofluorescence. Endometrial curettings from one case of chorioadenoma and three cases of hydatidiform mole showed cytoplasmic and extracellular fluorescence. One biopsy specimen of choriocarcinoma showed minimal cytoplasmic fluorescence and a second specimen had none. Endometrium from two premenopausal nongestational hysterectomy specimens, placenta from one case of anencephalic fetus, a normal fallopian tube, and a normal uterine cervix were all negative for specific immunofluorescence. Finally, umbilical cord did not show immunofluorescence. Examination of 20 methacrylate-embedded, Giemsa-stained sections of normal term placental tissue revealed no eosinophils other than the occasional typical peripheral blood eosinophil in a vascular space.
MBP in Tissue Extracts and Cyst Fluids.
Because of the prevalence and intensity of the placental immunofluorescence findings, we attempted to solubilize placental MBP for comparison with MBP previously purified from the eosinophil granule. Dose-response curves for placental extract and purified MBP tested in the two-site immunoradiometric assay are shown in Fig. 4a . The curves are superimposable down to very low concentrations, where the placental extract shows greater anti-MBP antibody-binding activity. The dose-response curves for all five placental extracts shown in Table II were not statistically different from each other or the MBP standard, regardless of the extraction protocol used. Table II shows that the highest yield of MBP from placenta resulted from collagenase digestion, reduction and alkylation, and acidification. Table  II ) was tested here. Extracts prepared by any of the protocols in Table II as determined in the double antibody inhibition assay for MBP. From this assay, cyst fluid contained 100 gg MBP/ml, a sixfold increase above the highest maternal serum levels measured in gestation. When placental extracts were subjected to gel permeation chromatography on Sephadex G-50, all of the immunoreactivity was associated with the void volume species, as has been shown for the serum MBP molecule of gestation (13) .
Discussion
The isolation of major basic protein from the eosinophil granule, its physicochemical properties, and its biological activities have been reviewed (3, 21) . Human MBP is a relatively small arginine-rich protein, which in solution behaves as a polycation having an isoelectric point >10. MBP has at least two solvated sulfhydryl groups and it readily self-associates in concentrated solutions to form polymeric molecules. MBP is largely protein bound in physiological fluids, on the basis of both charge and disulfide linkages. When MBP is polymerized or covalently bound to other proteins, its recognition by a variety of specific antisera is inhibited (6, 19) ; for this reason, quantitative immunochemical measurement requires prior reduction and alkylation under nondenaturing conditions.
In the guinea pig, MBP is the sole constituent of the crystalloid core of the eosinophil granule (22) . Human MBP is elevated in the serum of patients with eosinophilia, and the degree of elevation is correlated with the degree of eosinophilia (19) and with elevation of other eosinophil-related proteins such as Charcot-Leyden crystal protein (23) . MBP is found in high concentrations in the sputum of patients with bronchial asthma (11) and has been demonstrated by immunofluorescence in the mucus plugs obstructing the bronchi of patients who have died with asthma (15) . MBP provokes histamine release from basophils in a specific, noncytotoxic manner (12), but it is directly toxic to tracheal epithelium, other mammalian cells, and several helminths (3, 21) . MBP has, therefore, been postulated as a mediator of the bronchial epithelial damage in asthma and of eosinophil-directed helminthocidai immune responses.
We have recently discovered that serum levels of immunoreactive MBP are elevated throughout human pregnancy (13) . The degree of elevation correlates with the stage of gestation, with levels increasing from pre-gravid normals of <600 ng/ml to a plateau of ~7,500 ng/ml by the 20th wk of gestation. This elevation is comparable to the elevation of MBP seen in the serum of patients who have extreme degrees of peripheral blood eosinophilia, such as in the hypereosinophilic syndrome (19) . Because cord serum MBP levels were normal, because maternal serum levels began to fall after delivery, and because we were unable to show any peripheral blood eosinophilia or elevation of other eosinophilrelated proteins in serum of pregnant women with elevated serum levels of immunoreactive MBP, we postulated that the placenta is the source of this molecule. Here we show that immunoreactive MBP is localized in human placental tissue. The MBP localization is immunochemically specific, as shown by absorption experiments, and anatomically specific, as shown by its presence only in association with placental X cells and placental-site giant cells and its absence in maternal blood clot and nonreproductive maternal tissues. The cytotrophoblast and syncytiotrophoblast, which are the predominant cellular elements in placenta, are not associated with MBP immunofluorescence. It seems unlikely that maternal endometrial deciduai cells contribute to placental MBP immunofluorescence, because staining is seen in ectopic tubal pregnancy tissue where there are no maternal decidual cells present. Similarly, as shown in Fig.  3 , the maternal decidual cells in the areas of deep adenomyosis, removed from the placental insertion site, are not associated with MBP immunofluorescence, while the adjacent areas from the same specimen, at the placental insertion site, stain positively for MBP in and around the placental-site giant cells.
MBP immunofluorescence appears to be present throughout normal gestation, because we found specific staining in placental tissue from terminations of normal gestation as early as 6 wk after conception. Although some specimens from early gestation had extracellular staining as well as cytoplasmic staining of X cells and placental-site giant cells, in general, the earlier the gestation the more likely cytoplasmic fluorescence predominated over extracellular fluorescence. The presence of MBP immunofluorescence was unaffected by the occurrence of uterine labor; placental specimens obtained by elective cesarean section were indistinguishable from those delivered after spontaneous parturition. This was also true when tissues from terminations of pregnancy (vacuum extraction without hormonal or pharmacologic interventions) were compared with tissues from spontaneous abortion.
We used the method of Godfrey et al. (17) to search for placental eosinophiis because it offers two advantages over conventional histologic methods. Sections are thin enough to permit enumeration of single cells, and the tinctorial properties of mast cells, basophils, neutrophils, and eosinophils are the same as those usually obtained in peripheral blood, allowing unambiguous identification. In spite of these optimal conditions for observation, we were unable to demonstrate any tissue eosinophils in placental tissue in which abundant MBP immunofluorescence was found.
Quantitation of immunoreactive MBP in extracts of human placenta by both radioimmunoassay and immunoradiometric assay offers confirmatory evidence for the immunofluorescence findings. The observation that immunoreactive MBP concentrations in placental cyst fluid are more than six times higher than the highest levels measured in maternal serum discourages belief that MBP extracted from placenta is due solely to the content of maternal blood in the tissue. Localization of these very high concentrations of MBP to the placental cysts might be expected on the basis of our histologic and immunofluorescence finding and because prior observations have established the association of placental cysts with placental X cells, which are found lining the inner aspects of the cysts (24) .
The limited physicochemical data available for the MBP molecule in placenta and maternal serum suggest some differences in comparison with MBP isolated from the eosinophil granule. In the immunoradiometric assay, dose-response curves for placental extracts and granule MBP are superimposable over most of the working range of the assay, except at very low concentrations where the placental extract actually has greater anti-MBP antibody binding activity than granule MBP. In the double antibody inhibition assay used to compare cyst fluid with purified granule MBP, cyst fluid MBP completely displaced granule MBP from specific antibody and the slope of the dose-response curve for cyst fluid MBP was greater than that for granule MBP. Finally, as has been shown for the MBP in maternal serum (13) , the MBP in placental extracts appears at the void volume of a Sephadex G-50 column instead of at the expected elution volume for monomer MBP isolated from the eosinophil granule. This latter observation suggests that the placental MBP molecule is larger than the eosinophil granule monomer MBP, and it is reasonable to speculate that the failure of perfect slope concordance in dose-response studies is somehow related to this apparent molecular size difference.
The 0recise origin of placental X cells and placental-site giant cells is controversial and their function is unknown. Placental X cells were first described by Scipiades and Burg (25) , who noted their consistent location in placental septae, lining cystic structures, and in the basal decidual floor, where they are usually enmeshed in maternal flbrinoid, scattered among maternal decidual cells. Ultrastructural studies have shown that these cells possess a microvillus surface, welldeveloped Golgi apparatus, and extensive rough endoplasmic reticulum, suggesting very active protein biosynthetic activity (26) . Autoradiography using tritiated thymidine has revealed DNA synthesis in a substantial portion of these cells (24) , and immunofluorescence examinations for human chorionic gonadotrophin have been negative (27) . An association between severe abnormal proliferation of X cells and fetal intrauterine growth retardation has been reported (28) . In contrast, much less is known about the placental-site giant cell. This cell is found only in relation to maternal endometrial and myometrial cells at the placental insertion site. Immunofluorescence for human chorionic gonadotrophin in these cells has been reported positive and, using quinacrine fluorescence (for F bodies) in male gestations, a trophoblastic origin for placental-site giant cells has been reported (27) .
The immunofluorescence findings in this paper provide some immunochemical evidence to suggest that the X cells and the placental-site giant cell may be functionally related specialized derivatives of trophoblast. The placental-site giant cell has been postulated to play a key role in establishing the invasiveness of the trophoblastic mass at the time of implantation, and it is tempting to speculate that MBP, a cytotoxic molecule as isolated from the eosinophil, might be synthesized by such an invasive cell to mediate maternal decidual cell necrosis and enhance implantation. This hypothesis fails to account for continued production of MBP throughout gestation, however, and leaves unaddressed the function of MBP produced by the placental X cell.
Summary
We have recently reported that human pregnancy is characterized by a 10-to 20-fold elevation of eosinophil major basic protein (MBP) immunoreactivity in maternal blood. Here we show, by immunofluorescence, that placental tissue specifically binds antibody to MBP in and around the placental X cells and placental-site giant cells and, using thin plastic sections, that placenta has no infiltrating eosinophils. The X cells line the inner aspects of placental septal cysts, and the cyst fluid, obtained by aspiration, contains immunoreactive MBP at concentrations of 100 #g/ml, a sixfold greater concentration than the highest levels measured in maternal blood.
The soluble MBP immunoreactivities in placental homogenates and in maternal serum chromatograph identically on Sephadex G-50, and both these gesta-tional MBP molecules migrate as though substantially larger than the MBP found in serum from patients with hypereosinophilic syndrome or purified from the eosinophil granule. Our inability to demonstrate eosinophils in maternal blood or placental tissue, coupled with the large quantities of immunoreactive MBP highly localized in placental cysts and the chromatographic behavior of this molecule, suggest that the MBP detected in human gestation is produced by placenta.
